Physician profile
Ghada Afifi
NPI 1760573349
$7,998.92
in general payments reported to CMS, 2019-2025
16 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,002 · 2020: $13.50 · 2021: $31.14 · 2022: $528 · 2023: $3,029 · 2024: $1,051 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Food and Beverage | $1,624.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,953.70 | 2019-2022 | |
| Avita Medical Americas, LLC | $2,800.00 | 2023 | Recell |
| Mentor Worldwide LLC | $801.49 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $461.99 | 2024-2025 | Daxxify |
| Acera Surgical, INC. | $148.38 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lifenet Health | $132.40 | 2024 | Theragenesis Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $131.04 | 2022 | |
| Organogenesis INC. | $122.26 | 2024 | Puraply Wound Matrix |
| Abbvie INC. | $121.68 | 2025 | |
| Merz North America, INC. | $51.52 | 2020-2023 | Xeomin |
| Boston Scientific Corporation | $51.35 | 2019 | |
| Davol INC. | $28.38 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $18.08 | 2019 | |
| Convatec INC. | $16.85 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghada Afifi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.